Brokerage Asset Management Investment Advice Corporate Finance Custody
Login
Contact Us
 
We are pleased to announce our collaboration with Pershing Securities Ltd, an indirect wholly owned subsidiary of The Bank of New York Mellon Corporation (BNY Mellon).
Click here for more.

MARKET VALUES
ABOUT

MeritKapital is a Cyprus Securities and Exchange Commission (CySec) regulated investment firm that renders the below mentioned services:

MeritKapital is a boutique investment firm that best tailors to investors’ interests and is backed by the financial infrastructure of renowned banks. Based in Cyprus, the most efficient EU tax jurisdiction, and armed with the "Single EU Passport", MeritKapital operates under an ideal business environment with free mobility (offering of financial products and services) within the opportune environment of the EU periphery. Moreover, through its post, the firm offers a stronger regulatory capital markets framework vs. prior regulations through Cyprus's adoption of the Markets in Financial Instruments Directive (MiFid).

Second, MeritKapital affords a competitively priced trading platform for private clients and institutional investors alike to access a full range of financial instruments; stocks, bonds, options, commodities, foreign exchange, CFDs amongst others, on global exchanges.

Last, with the guidance of a proven team of Board of Directors and a wide network of clients & affiliates of Meritservus, our Cyprus Investment Firm (CIF) endured perhaps the greatest financial crisis post the 1930s Great Depression unscathed and with an impressive comparative performance. MeritKapital will continue to pursue this successful trend.

 


NEWS

Fantasy Earnings Trader: Fantasy Earnings leader wins week with Netflix
Sat, 28 Jan 2012 00:27:15 GMT
Prescient bet on volatile video provider boosts gains.


SportsWatch: Athletics’ Olympic year sees new events, sponsors
Sat, 28 Jan 2012 00:27:15 GMT
Ahead of the London Games in July, the sport of track and field is launching two events and signing new sponsorship deals


After Hours: PharMerica dives, Amylin surges after hours
Sat, 28 Jan 2012 00:27:15 GMT
Shares of the pharmacy-management services firm drop as the FTC seeks to block a bid for the company. Meanwhile, Amylin and Alkermes receive FDA approval for their shared diabetes treatment.



  MeritKapital Ltd © 2011
Corporate Documents | Legal | Security | Privacy | Contact Us